Join Christophe Eggmann, Investment Director of GAM Health Innovation Equity, and Dr Jenna Denyes, Healthcare Analyst, as he discusses:
- How the recent Covid-19 outbreak has affected the health sector, both in relation to the virus and more broadly.
- Why he believes the impact on biopharmaceutical companies is temporary and manageable.
- What opportunities he believes could emerge in the coming weeks and months.
Register for the webcast on 8 April 2020 to find out more and pose your questions to Christophe.